Turn Therapeutics Inc.
TTRX
$4.85
-$0.39-7.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -58.56% | -10.78% | 22.85% | -- | -- |
| Total Depreciation and Amortization | 24.75% | 15.79% | 7.73% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10,593.75% | 62.81% | -43.59% | -- | -- |
| Change in Net Operating Assets | -21.03% | -55.97% | -100.78% | -- | -- |
| Cash from Operations | -24.79% | -11.36% | 1.18% | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.06% | -48.05% | -124.89% | -- | -- |
| Cash from Investing | -5.06% | -48.05% | -124.89% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,201.43% | 537.73% | 130.48% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,201.43% | 537.73% | 130.48% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 317.82% | 200.83% | 66.55% | -- | -- |